alexa
Reach Us +441474556909
Selective Adhesion Of Human Cancer Cells On A Blood Compatible Polymer | 6589
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Selective adhesion of human cancer cells on a blood compatible polymer

International Conference and Exhibition on Nanotechnology & Nanomedicine

Satomi Yagi, Chisato Kuroki, Iku Konno, Mayo Nikaido and Masaru Tanaka

Posters: J Nanomedic Nanotechnol

DOI: 10.4172/2157-7439.S1.07

Abstract
The isolation of circulating tumor cells (CTCs) is attractive attention because it has clinical significance in cancer therapy and it would enable earlier diagnosis of metastasis. If CTCs can be separated selectively from peripheral blood with intact, it is useful for the screening of anti cancer drugs. Here, we investigated selective adhesion and growth of human cancer cells on poly (2-methoxyethyl acrylate)(PMEA) 1) which shows excellent blood compatibility. PMEA was coated on Polyethylene terephthalate(PET) at twice by a spin-coater. We confirmed the coating by static water contact-angle and X-ray photoelectron spectroscopy. Then we observed cell adhesion and growth on PMEA, Glass and PET by confocal laser scanning microscopy and scanning electron microscopy. The number of adherent cells on PMEA showed almost the same those on Glass and PET after 15, 30 minites, and 1 hour. It is known that human cancer cells and platelets can be adhered easily on both Glass and PET. Our results suggest that the PMEA has a potential for a diagnosis device of cancer without cell staining. 2) Furthemore, the growth of cancer cells on PMEA was lower than that on Glass. It is expected to growth inhibition of cancer cells using blood compatible polymers and new therapies without anti cancer drugs. 1) M. Tanaka. et. al., J. Biomed. Mater. Res. 68A. 684-695(2004) 2) M. Tanaka, S. Yagi et al., JP Patent 2010-256467, 17/11/2010.
Biography
S.Yagi is a Ph.D student at Biomaterials Science group, Department of Biochemical Engineering
Top